Anaplasmosis Management: New Label Brings Options for Big Worry
Victoria G. Myers
Progressive Farmer
A new treatment option, Baytril 100-CA1 Injectable Solution (enrofloxacin), has been granted conditional approval by the FDA for treatment of clinical cases of anaplasmosis in cattle. The product is expected to be available for this use beginning in May.